Seroprevalence of SARS-COV-2 in a rural population of Ecuador
Abstract
The present study seeks to determine the total IgG, IgM and IgA antibodies against SARS COV-2 in a population of the Ecuadorian highlands. The sample universe is comprised of 318 adults, 187 men and 131 women. The percentage of positivity was 42.5%. Prior to sampling, a survey was conducted on the symptoms, diagnostic tests and vaccination of SARS COV-2. Correlation of positive results was found for our test with participants who presented symptoms of SARS COV-2 infection confirmed by PCR (89.7%), also correlation between people who claimed not to have had symptoms of SARS COV-2 infection with test results negative (75.6%). There was a small number of results classified as false negatives (2.8%). In addition, the results of people who claimed to have never had symptoms of SARS COV-2 infection and obtained positive results in the antibody test (14.7%) that would be considered as asymptomatic carriers.
Downloads
References
2. Rostami A, Sepidarkish M, Leeflanf M, et al. (2020). SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analisis. Clin Micro and Infection. Published Oct 23, 2020. DOI: https://doi.org/10.1016/j.cmi.2020.10.020
3. Huang C, Wang Y, Li X, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497-506
4. Sidiq Z, Hanif M, Dwivedi K, et al. (2020). Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc. Dec; 67(4): S163-S166. Doi: 10.1016/j.ijtb.2020.07.034
5. Acurio D, Gómez A, Orellana D, Vega B, Charry R, et al. (2020) Estudio de seroepidemiología de la infección por SARS COV-2 en el cantón Cuenca. https://ucuenca.edu.ec.
6. Álava N, Ávila M, Castro J. et al. (2021) Seroprevalencia de la COVID-19, factores de riesgo y protocolos de bioseguridad en el personal de salud de la ciudad de Jipijapa provincia de Manabí, Ecuador. Doi: 10.23857/pc.v6i7.2825
Copyright (c) 2021 Rural Family Practice
This work is licensed under a Creative Commons Attribution 4.0 International License.